Your session is about to expire
← Back to Search
Apollo Device for Metastatic Breast Cancer
This trial will study whether the Apollo wearable device, similar to a FitBit, can help with symptoms of fatigue and pain in patients with Metastatic Breast Cancer.
- Breast Cancer
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a Location
Who is running the clinical trial?
- You are taking beta blocker medication.You are taking medication for a serious mental illness.
- Group 1: Apollo Armband
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Would I qualify to be involved in this scientific experiment?
"This clinical trial is looking to recruit 30 participants between 18 and 100 years old who suffer from fatigue. In order for patients to be eligible, they must have a diagnosis of metastatic breast cancer with a fatigue score of 4 or higher at their last clinic visit."
What is the present capacity for participants in this experiment?
"Affirmative. Evidence on clinicaltrials.gov reveals that this trial, first posted in February 2021 is actively recruiting patients to its single location. Thus far, 30 participants have joined the study with a recent update date of January 27th 2022."
Does this research endeavor include individuals over the age of twenty?
"This trial necessitates that any participating patient is between 18 and 100 years old. Additionally, there are separate trials for those under 18 (76) and over 65 (2367)."
Is the research team accepting new participants for this experiment?
"Affirmative. Perusal of clinicaltrials.gov indicates that this medical experiment is currently enrolling participants - it was first published on February 1st, 2021 and underwent its most recent update on January 27th 2022. 30 patients are needed at a single site for the study to be completed successfully."
What are the fundamental aims of this clinical experiment?
"This trial, which has an 8 week time frame and utilises the PROMIS system to measure outcomes, aims to ascertain changes in fatigue. Secondary objectives include gauging levels of pain intensity (3-15) and interference with important aspects of life (6-30), determining usage patterns for analgesic medications, and calculating overall sleepf pain intensity (3-15) and interference with important aspects of life (6-30), determining usage patterns for analgesic medications, and calculating overall sleep quality scores from "very poor" through to "very good" (8-45)."
Share this study with friends